Recombinant Human MCM3 Protein: Handling & Application Protocol

Recombinant Human MCM3 Protein is a key component of the MCM2–7 replicative helicase complex that licenses and unwinds DNA at replication origins, making it an essential research tool for studying eukaryotic DNA replication initiation and cell-cycle checkpoint biology.

Product Name

Recombinant Human MCM3 Protein

SKU

rp371574

Protein Function

Subunit of the MCM2–7 helicase complex; essential for DNA replication licensing and origin unwinding

Research Applications

DNA replication studies, cell-cycle analysis, protein–protein interaction assays, biochemical reconstitution

Recommended Storage

Store lyophilized protein at –20 °C or –80 °C; avoid repeated freeze–thaw cycles

Host/Expression System

Refer to product datasheet (rp371574) for confirmed expression system details

Background: MCM3 and the Replicative Helicase Complex

Minichromosome Maintenance Protein 3 (MCM3) is an evolutionarily conserved AAA+ ATPase that forms an integral subunit of the heterohexameric MCM2–7 complex. This complex serves as the core of the eukaryotic replicative helicase and is loaded onto replication origins during the G1 phase of the cell cycle as part of the pre-replicative complex (pre-RC). Upon S-phase entry, the MCM2–7 complex is activated by CDC7/DBF4 and CDK2/Cyclin E kinases, enabling origin unwinding and bidirectional replication fork progression.

MCM3 contributes to both the structural integrity of the hexameric ring and the regulation of helicase activity. Dysregulation of MCM3 expression has been associated with genomic instability and has been reported in various human cancers, making it a subject of interest in oncology and checkpoint biology research. Recombinant Human MCM3 Protein (rp371574) enables in vitro investigation of these mechanisms.

Materials and Equipment

Before beginning, ensure the following materials are available:

• Recombinant Human MCM3 Protein (Aladdin Scientific, SKU: rp371574)
• Sterile, ultrapure water or reconstitution buffer as specified on the product datasheet
• Microcentrifuge tubes (low-protein-binding, 1.5 mL)
• Micropipettes and calibrated tips
• Benchtop microcentrifuge
• Ice bucket and wet ice
• –80 °C ultra-low temperature freezer
• SDS-PAGE gel system and western blot apparatus (for quality verification)
• Protein quantification reagents (e.g., BCA or Bradford assay kit)
• Protease inhibitor cocktail (optional, for downstream assays)

Refer to the rp371574 product datasheet for the confirmed reconstitution buffer composition, protein concentration, and purity specifications before proceeding.

Step-by-Step Protocol: Reconstitution and Aliquoting

Step 1 – Thaw and equilibrate. Remove the vial of Recombinant Human MCM3 Protein from storage and allow it to equilibrate to room temperature for 10–15 minutes. Do not apply heat. If the product is supplied lyophilized, proceed directly to Step 2.

Step 2 – Reconstitution. Briefly centrifuge the vial (1,000 × g, 30 seconds) to consolidate the lyophilized material at the bottom. Add the volume of sterile reconstitution buffer specified in the product datasheet dropwise along the inner wall of the vial. Gently swirl — do not vortex — until the protein is fully dissolved.

Step 3 – Incubation. Allow the reconstituted solution to stand on ice for 5 minutes to ensure complete dissolution.

Step 4 – Clarification. Centrifuge at 10,000 × g for 2 minutes at 4 °C to remove any insoluble aggregates. Carefully transfer the supernatant to a fresh low-binding microcentrifuge tube.

Step 5 – Quantification. Measure the protein concentration using a BCA or Bradford assay. Compare to the datasheet specification to confirm acceptable recovery.

Step 6 – Aliquoting. Divide the reconstituted protein into single-use aliquots appropriate for your experimental needs. This minimizes freeze–thaw cycles, which degrade protein activity and integrity.

Step 7 – Storage. Flash-freeze aliquots in liquid nitrogen or on dry ice, then store at –80 °C. For short-term use within 1 week, aliquots may be stored at 4 °C; addition of a carrier protein such as 0.1% BSA is recommended if further dilution is required.

Quality Verification and Troubleshooting

Quality verification. Run an aliquot on a reducing SDS-PAGE gel and stain with Coomassie Blue or perform western blot using an anti-MCM3 antibody. Confirm that the dominant band corresponds to the expected molecular weight of MCM3 (approximately 90.9 kDa for the full-length human protein; verify exact tag-adjusted MW from the rp371574 datasheet). Purity should meet the specification stated on the datasheet.

Troubleshooting – Protein aggregation: If visible precipitate forms after reconstitution, gently warm to 37 °C for 5 minutes and re-centrifuge. If aggregation persists, the protein may have undergone freeze–thaw damage; use a freshly thawed aliquot.

Troubleshooting – Low activity in functional assays: Ensure the assay buffer is compatible with the storage buffer components. Avoid exposure to detergents above critical micelle concentration. Confirm that reducing agents (e.g., DTT) are present if required by the downstream assay.

Troubleshooting – Unexpected band size: Account for any affinity tag appended to the recombinant construct. Refer to the rp371574 datasheet for the confirmed tag type and position.

Recommended Experimental Applications

Recombinant Human MCM3 Protein (rp371574) is suitable for a range of in vitro research applications, including but not limited to:

• Biochemical reconstitution: Assembly of partial or complete MCM2–7 hexameric complexes to study helicase loading and activation mechanisms.
• Protein–protein interaction studies: Co-immunoprecipitation, pull-down assays, or surface plasmon resonance (SPR) to map MCM3 interaction surfaces with other replisome components (e.g., MCM2, MCM5, Cdt1, ORC subunits).
• Enzyme activity assays: ATPase activity measurements to assess the contribution of MCM3 to the collective ATPase activity of the hexamer.
• Structural studies: Use as an antigen for antibody generation or as a component in cryo-EM sample preparation.
• Drug discovery: Screening of small-molecule inhibitors targeting the MCM3 ATPase domain or protein–protein interaction interfaces relevant to cancer biology.

Always optimize protein concentration, buffer conditions, and incubation parameters for each specific application. Refer to relevant literature and the rp371574 datasheet for guidance.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human MCM3 Protein (rp371574)?

The recommended reconstitution buffer composition and volume are specified in the rp371574 product datasheet. Generally, a buffer containing 20–50 mM Tris-HCl (pH 7.5–8.0), 150 mM NaCl, and 10% glycerol is suitable for MCM-family proteins, but always confirm with the datasheet before use.

How many freeze–thaw cycles can Recombinant Human MCM3 Protein tolerate?

For optimal activity and integrity, repeated freeze–thaw cycles should be avoided. We recommend aliquoting the reconstituted protein into single-use volumes and storing them at –80 °C. Each additional freeze–thaw cycle risks protein aggregation, loss of secondary structure, and reduced functional activity.

Is Recombinant Human MCM3 Protein suitable for use in helicase activity assays?

MCM3 alone does not possess robust helicase activity; helicase unwinding activity requires assembly of the complete MCM2–7 hexamer and additional co-factors such as CDC45 and the GINS complex (forming the CMG complex). Recombinant Human MCM3 Protein (rp371574) can be used to reconstitute partial complexes or as a component in full CMG reconstitution experiments for in vitro helicase assays.

How should I verify the purity of the MCM3 protein after reconstitution?

Run an aliquot on a reducing SDS-PAGE gel (typically 8–10% polyacrylamide) and stain with Coomassie Blue to visually assess purity. For identity confirmation, perform western blot analysis using a validated anti-human MCM3 antibody. The predominant band should correspond to the expected molecular weight as stated in the rp371574 datasheet.

Can Recombinant Human MCM3 Protein be used for structural studies such as cryo-EM?

Yes, recombinant MCM subunits including MCM3 have been used in structural biology studies. For cryo-EM applications, ensure the protein is highly pure and monodisperse, as confirmed by dynamic light scattering (DLS) or size-exclusion chromatography (SEC). Buffer optimization to minimize preferred orientation and aggregation is recommended before grid preparation.

References

1. Bochman ML, Schwacha A. The Mcm2-7 complex has in vitro helicase activity. Molecular Cell. 2008;31(2):287–293. doi:10.1016/j.molcel.2008.05.020
2. Remus D, Diffley JF. Eukaryotic DNA replication control: lock and load, then fire. Current Opinion in Cell Biology. 2009;21(6):771–777. doi:10.1016/j.ceb.2009.08.002
3. Georgescu R, Yuan Z, Bai L, et al. Structure of eukaryotic CMG helicase at a replication fork and implications to replisome architecture and origin initiation. Proceedings of the National Academy of Sciences USA. 2017;114(5):E697–E706. doi:10.1073/pnas.1620500114
4. Aladdin Scientific. Recombinant Human MCM3 Protein (rp371574) Product Datasheet. Aladdin Scientific; accessed 2024.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.